BFRIW

Key Statistics

About Biofrontera Inc. Warrants

Biofrontera Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative dermatological therapies, with a particular focus on skin cancer treatments. Its flagship product, Ameluz, is a leading therapy for actinic keratosis, supported by a state-of-the-art photodynamic therapy system designed to maximize patient outcomes. Committed to expanding its product portfolio and market presence, Biofrontera is poised to address critical unmet needs in skin health while fostering strategic partnerships to enhance its growth trajectory. With an increasing global demand for effective skin cancer solutions, the company is strategically positioned for future growth and success in this vital healthcare sector.

Fundamentals